Residency · Birmingham, AL
Sponsored by University of Alabama Hospital
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
The New England journal of medicine · 2021 · 288 citations · Prescott Atkinson
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2023 · 110 citations · John Anderson
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
The Journal of allergy and clinical immunology · 2021 · 132 citations · John Anderson
Atopic Dermatitis: A Review of Diagnosis and Treatment.
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2024 · 33 citations · Robert Hostoffer
Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria.
Allergy · 2025 · 25 citations · John Anderson
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial.
The journal of allergy and clinical immunology. In practice · 2024 · 25 citations · John Anderson
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021 · 94 citations · John Anderson
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.
Advances in therapy · 2025 · 14 citations · John Anderson